Affiliation:
1. Hospital for Skin Diseases and Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
2. Chronic Disease Research Center, Medical College, Dalian University
Abstract
Abstract
Bullous pemphigoid (BP) is a complex inflammatory process with elevated levels of autoantibodies, eosinophils, neutrophils, and various cytokines. Hematological inflammatory biomarkers can reflect inflammatory state in various diseases. Up to now, the correlations of hematological inflammatory biomarkers and disease activity of BP remain unknown. The purpose of this study was to clarify the associations between hematological inflammatory biomarkers and disease activity of BP. The levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet-to-neutrophil ratio (PNR) and mean platelet volume (MPV) of 36 untreated BP patients were detected by routine blood tests, and their correlations with clinical characteristics of BP were statistically analyzed. The Bullous Pemphigoid Disease Area Index (BPDAI) was used to measure disease activity of BP. The mean levels of NLR, PLR, PNR and MPV in 36 untreated BP patients were 3.9, 157.9, 45.7 and 9.4 fl, respectively. The levels of NLR were positively correlated to BPDAI Erosion/Blister Scores (p < 0.01). The levels of NLR and PLR were both positively correlated to BPDAI without Damage Score (both p < 0.05) and BPDAI Total Score (both p < 0.05). No correlation was found in other statistical analyses between hematological inflammatory markers and clinical characteristics in BP patients involved in the present study. Therefore, NLR and PLR are positively correlated with disease activity of BP.
Publisher
Research Square Platform LLC
Reference46 articles.
1. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII;Nishie W;J Dermatol Sci.,2014
2. The pathophysiology of bullous pemphigoid;Kasperkiewicz M;Clin Rev Allergy Immunol. 2007
3. Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases;Goletz S;Exp Dermatol.,2017
4. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity;Dopp R;J Am Acad Dermatol,2000
5. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid;Daneshpazhooh M;Arch Dermatol Res.,2018